Your browser doesn't support javascript.
loading
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Vergara-Cadavid, Juliana; Johnson, P Connor; Kim, Haesook T; Yi, Alisha; Sise, Meghan E; Leaf, David E; Hanna, Paul E; Ho, Vincent T; Cutler, Corey S; Antin, Joseph H; Gooptu, Mahasweta; Kelkar, Amar H; Wells, Sophia L; Nikiforow, Sarah; Koreth, John; Romee, Rizwan; Soiffer, Robert J; Shapiro, Roman M; Gupta, Shruti.
Afiliación
  • Vergara-Cadavid J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Johnson PC; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.
  • Kim HT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard School of Public Health, Boston, Massachusetts.
  • Yi A; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.
  • Sise ME; Division of Nephrology, Massachusetts General Hospital, Massachusetts.
  • Leaf DE; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hanna PE; Division of Nephrology, Massachusetts General Hospital, Massachusetts.
  • Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kelkar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wells SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shapiro RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gupta S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: sgupta21@bwh.harvard.edu.
Transplant Cell Ther ; 29(7): 455.e1-455.e9, 2023 07.
Article en En | MEDLINE | ID: mdl-37015320
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Lesión Renal Aguda / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Lesión Renal Aguda / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article